Skip to main content

Latest News

Novartis Secures Prostate Cancer Treatment With Endocyte Deal
INVESTING
ECYTNVS

Novartis Snaps up Prostate Cancer Treatment with Endocyte Deal

By Paul Whitfield
Oct 18, 2018 9:16 AM EDT
Dow Charges Higher, Wall Street Rebounds as Italy Fears Ease
MARKETS
AXPNUEDHR

Facebook, Fed Minutes, AmEx, PayPal and Endocyte - 5 Things You Must Know

By Joseph Woelfel
Oct 18, 2018 7:17 AM EDT
Small-Cap Stocks Are Doing Something They Haven't Done Consistently in 3 Years
OPINION
AOIAPEIBXC

Small-Cap Stocks Are Doing Something They Haven't Done Consistently in 3 Years

By Brian Sozzi
Mar 14, 2018 6:23 PM EDT
Corbus Pharma Bear Thesis Is Alive and Well on Sclerosis Drug Data Skewed Positive
STOCKS
CRBPOGXIADHD

Corbus Pharma bear thesis is alive and well

By Adam Feuerstein
Nov 15, 2016 6:55 AM EST
Achillion Shares Are Plunging on Termination of Hepatitis C Pact
INVESTING
BCLIECYTSNSS

4 Biotech Stocks Under $10 to Trade for Breakouts

By Roberto Pedone
Mar 24, 2015 2:13 PM EDT

Recommended for You

PRESS RELEASES

AXSOME ALERT: Bragar Eagel & Squire, P.C. Announces That A Class Action Lawsuit Has Been Filed Against Axsome Therapeutics, Inc. And Encourages Investors To Contact The Firm

By Business Wire
PRESS RELEASES

MEI PHARMA ALERT: Bragar Eagel & Squire, P.C. Is Investigating MEI Pharma, Inc. On Behalf Of MEI Stockholders And Encourages Investors To Contact The Firm

By Business Wire
PRESS RELEASES

UNITY ALERT: Bragar Eagel & Squire, P.C. Is Investigating Unity Software, Inc. On Behalf Of Unity Stockholders And Encourages Investors To Contact The Firm

By Business Wire
PRESS RELEASES

Paul Ricci, Chief Auditor, Wells Fargo (Photo: Wells Fargo)

By Business Wire